Neoadjuvant therapy in breast cancer as a casis for drug approval Journal Article

  

Authors:	Berry, D. A.; Hudis, C. A.
Article Title:	Neoadjuvant therapy in breast cancer as a casis for drug approval
Keywords:	survival; treatment outcome; disease-free survival; survival analysis; disease course; mortality; antineoplastic agents; drug approval; united states; united states food and drug administration; adjuvant therapy; disease free survival; neoadjuvant therapy; antineoplastic agent; reproducibility; reproducibility of results; neoplasm recurrence, local; risk factors; food and drug administration; pathology; breast neoplasms; risk factor; time; time factors; risk assessment; statistical analysis; data interpretation, statistical; disease progression; tumor recurrence; adverse effects; humans; human; female
Journal Title:	JAMA Oncology
Volume:	1
Issue:	7
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2015-10-01
Start Page:	875
End Page:	876
Language:	English
DOI:	10.1001/jamaoncol.2015.1293
PUBMED:	26181139
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-84965094393&partnerID=40&md5=a3de0223a2e084248d7cec480781cf30
Notes:	Article -- Export Date: 2 June 2016 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/93800